The Metabolic Classroom with Dr. Ben Bikman

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Summary:
In this lecture, Dr. Ben Bikman explores how skeletal muscle fiber type influences insulin sensitivity and diabetes risk. While muscle is the body’s largest site of insulin-stimulated glucose disposal, not all muscle behaves the same. Different fiber types carry different amounts of the molecular machinery needed to respond to insulin, take up glucose, store it, and burn it.

He begins by distinguishing the two major muscle fiber types: type 1 slow-twitch and type 2 fast-twitch. Type 1 fibers are more oxidative, with greater mitochondrial density, while type 2 fibers are more glycolytic and fatigue more quickly. Importantly, type 1 fibers contain more insulin receptors, GLUT4 transporters, and key enzymes involved in glucose handling, helping explain why a higher proportion of these fibers is associated with better insulin sensitivity.

Dr. Bikman then connects these differences to real-world metabolic risk. Studies show that individuals with fewer type 1 fibers can have significantly lower insulin sensitivity—even when they appear healthy by standard markers. He also explores how these patterns may contribute to ethnic differences in diabetes risk across populations.

The key takeaway is that fiber type is not destiny. While genetics plays a role, exercise can improve muscle’s glucose-disposal capacity. Most importantly, total muscle mass matters more than fiber type alone, making resistance training a powerful tool for protecting metabolic health.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Summary:
GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time.

Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1?

Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can make L-cells insulin resistant, reducing their ability to secrete GLP-1 when needed. This may create a vicious cycle: high insulin suppresses GLP-1, low GLP-1 removes metabolic brakes, and the resulting larger glucose and insulin spikes further worsen the problem over time.

The lecture reframes GLP-1 deficiency as a potential consequence of chronic hyperinsulinemia rather than an isolated defect. While GLP-1 drugs can bypass this dysfunction and improve outcomes, they do not repair the underlying cause—making long-term strategies that lower chronically elevated insulin levels more fundamental.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Creatine supports brain function by rapidly regenerating ATP, making it essential for cognitive performance, especially under conditions of stress or low baseline levels. Clinical evidence shows it can improve memory, attention, mood, and resilience—particularly in vegetarians, older adults, women, and sleep-deprived individuals.

Summary:
Creatine is widely known as a muscle-building supplement, but in this lecture, Dr. Ben Bikman reveals its far more important and underappreciated role in brain function. Creatine acts as a rapid energy buffer through the phosphocreatine system, allowing brain cells to regenerate ATP within milliseconds during periods of high demand. Because the brain has extremely high energy needs and limited energy storage, this system is critical for maintaining cognitive performance, neurotransmitter signaling, and overall brain health.

Dr. Bikman walks through the human clinical evidence showing that creatine supplementation can meaningfully improve cognitive function, particularly in individuals with lower baseline creatine levels or increased metabolic stress. These groups include vegetarians and vegans, older adults, and women—each of whom tend to have lower creatine availability or higher demand. Studies show improvements in memory, intelligence, attention, and executive function, especially when the brain is under strain, such as during sleep deprivation.

The lecture also explores emerging research linking creatine to depression, traumatic brain injury, and neurodevelopmental disorders. In multiple randomized trials, creatine supplementation enhanced antidepressant responses, improved brain energy metabolism, and reduced cognitive impairment following sleep loss or injury. The overall message is clear: creatine is not just a performance supplement—it is a critical molecule for brain energy, cognition, and resilience under stress.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

#Creatine #BrainHealth #CognitivePerformance #MemoryBoost #MetabolicHealth #BrainEnergy #ATP #Phosphocreatine #SleepDeprivation #MentalPerformance #NeuroScience #DepressionTreatment #BrainMetabolism #SupplementScience #DrBenBikman #MetabolicClassroom #HealthOptimization #FocusAndMemory #BrainFuel #NutritionScience
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Most people think of gum disease as a local dental issue, but this lecture reveals a much broader and more consequential reality. Dr. Ben Bikman explains how the mouth serves as a gateway to systemic inflammation, particularly when periodontal disease allows bacteria and their toxic byproducts to enter the bloodstream. Once this happens, oral pathogens—especially P. gingivalis—can drive chronic inflammation, disrupt mitochondrial function, and contribute directly to insulin resistance.

At the mechanistic level, Dr. Bikman outlines several pathways linking oral health to metabolic dysfunction. These include cytokine spillover (where inflammatory signals interfere with insulin signaling), direct degradation of insulin receptors by bacterial enzymes, dysregulation of liver glucose metabolism, and disruption of the gut microbiome. Together, these effects create a persistent inflammatory state that impairs glucose control and increases the risk of type 2 diabetes—even in individuals without obesity.

The lecture also explores the strong epidemiological evidence supporting this connection, including studies showing that treating periodontal disease can significantly improve blood sugar control. Dr. Bikman further connects oral health to cardiovascular disease, highlighting how oral bacteria and endotoxins contribute to atherosclerosis. The takeaway is clear: oral health is not separate from metabolic health—it is a critical and often overlooked component of it.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.

📢 Ask Dr. Bikman’s Digital Mind (multilingual):
https://benbikman.com/ben-bikmans-digital-ai-mind

📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com

Topic:
Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease.

Summary:
Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology.

A central theme of the lecture is ivermectin’s impact on mitochondria, particularly its ability to inhibit complex I of the electron transport chain. This disruption creates an energy crisis within cells, activates AMPK, suppresses mTOR signaling, and can ultimately trigger apoptosis in cancer cells. Notably, these effects appear to be selective, with cancer cells showing greater sensitivity than healthy cells. Additional mechanisms—including inhibition of PAK1 and synergy with existing chemotherapy agents—further support ivermectin’s potential as a therapeutic candidate in oncology.

Beyond cancer, ivermectin demonstrates meaningful metabolic effects. It reduces inflammation through suppression of NF-kappaB, activates AMPK, and influences glucose metabolism via FXR signaling. Preclinical studies show improvements in insulin sensitivity, glucose control, liver health, and even adipocyte behavior. While human data is still limited, Dr. Bikman emphasizes that the mechanistic consistency across pathways warrants serious clinical investigation rather than dismissal.

References:
For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com

NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions.

Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884

Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb

Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)
Hosted on Acast. See acast.com/privacy for more information.